By Associate Professor Meg Jardine

Journal articles

Kang A; Smyth B; Neuen BL; Heerspink HJL; Di Tanna GL; Neal B; Zhang H; Hockham C; Agarwal R; Bakris GL; Charytan DM; de Zeeuw D; Greene T; Levin A; Pollock CA; Wheeler DC; Zinman B; Mahaffey KW; Perkovic V; Jardine MJ, 2020, 'Canagliflozin and Risk of Skin and Soft Tissue Infections in People with Diabetes Mellitus and Kidney Disease in the CREDENCE Trial', Journal of the American Society of Nephrology, 31, pp. 344 - 344, http://dx.doi.org/10.1681/asn.20203110s1344a

Oshima M; Neuen BL; Li J; Perkovic V; Charytan DM; de Zeeuw D; Edwards R; Greene T; Levin A; Mahaffey KW; De Nicola L; Pollock CA; Rosenthal N; Wheeler DC; Jardine MJ; Heerspink HJL, 2020, 'Early Change in Albuminuria with Canagliflozin (CANA) Predicts Kidney and Cardiovascular (CV) Outcomes', Journal of the American Society of Nephrology, 31, pp. 344 - 344, http://dx.doi.org/10.1681/asn.20203110s1344b

Levin A; Neuen BL; Mahaffey KW; Cannon CP; Jardine MJ; Heerspink HJL; Neal B; Arnott CG; Zhou Z; Charytan DM; Agarwal R; Bakris GL; de Zeeuw D; Greene T; Wheeler DC; Rosenthal N; Zhang H; Zinman B; Perkovic V; Pollock CA, 2020, 'Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes by Baseline Loop Diuretic Use: Data from the CREDENCE Trial', Journal of the American Society of Nephrology, 31, pp. 342 - 342, http://dx.doi.org/10.1681/asn.20203110s1342a

Young TK; Li J; Kang A; Heerspink HJL; Hockham C; Arnott CG; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine MJ, 2020, 'Effects of Canagliflozin on Major Adverse Cardiovascular Events in Patients with Different Baseline Levels of Type 2 Diabetes Disease Severity: Results from the CANVAS Program', Journal of the American Society of Nephrology, 31, pp. 344 - 344, http://dx.doi.org/10.1681/asn.20203110s1344c

Bakris GL; Jardine MJ; Zhou Z; Heerspink HJL; Li Q; Agarwal R; Charytan DM; Oh R; Pollock CA; Wheeler DC; de Zeeuw D; Zhang H; Zinman B; Mahaffey KW; Perkovic V, 2020, 'Renal, Cardiovascular (CV), and Safety Outcomes of Canagliflozin (CANA) According to Baseline Albuminuria: A CREDENCE Secondary Analysis', Journal of the American Society of Nephrology, 31, pp. 328 - 328, http://dx.doi.org/10.1681/asn.20203110s1328a

Jardine M; Zhou Z; Heerspink HJL; Li Q; Agarwal R; Bakris G; Charytan DM; Oh R; Pollock C; Wheeler DC; Zeeuw DD; Zhang H; Zinman B; Mahaffey KW; Perkovic V, 2020, 'SAT-156 RENAL, CARDIOVASCULAR, AND SAFETY OUTCOMES OF CANAGLIFLOZIN ACCORDING TO BASELINE ALBUMINURIA: A CREDENCE SECONDARY ANALYSIS', Kidney International Reports, 5, pp. S67 - S67, http://dx.doi.org/10.1016/j.ekir.2020.02.166

Hockham C; Bao L; Tiku A; Badve S; Gallagher MP; Jardine MJ; Jha V; Woodward M; Jun M, 2020, 'Sex Differences in CKD Prevalence in Asia: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 31, pp. 179 - 179, http://dx.doi.org/10.1681/asn.20203110s1179c

OSHIMA M; Wong MG; Hara A; Toyama T; Jun M; Jardine M; Pollock C; Woodward M; Chalmers J; Perkovic V; Wada T, 2020, 'SUN-161 CIRCULATING AUTOANTIBODIES TO ERYTHROPOIETIN RECEPTOR AND KIDNEY DISEASE PROGRESSION IN TYPE 2 DIABETES MELLITUS: RESULTS FROM THE ADVANCE STUDIES', Kidney International Reports, 5, pp. S267 - S267, http://dx.doi.org/10.1016/j.ekir.2020.02.690

Arnott C; Li J-W; Cannon CP; Neuen B; Heerspink HL; Neal B; Charytan DM; Agarwal R; Bakris GL; De Zeeuw D; Greene T; Levin A; Pollock C; Chang T; Rosenthal N; Zhang H; Zinman B; Perkovic V; Jardine M; Mahaffey K, 2020, 'THE EFFECTS OF CANAGLIFLOZIN ON HEART FAILURE AND CARDIOVASCULAR DEATH BY BASELINE PARTICIPANT CHARACTERISTICS: ANALYSIS OF THE CREDENCE TRIAL', Journal of the American College of Cardiology, 75, pp. 674, http://dx.doi.org/10.1016/s0735-1097(20)31301-2

Smyth B; van den Broek-Best O; Hong D; Howard K; Rogers K; Zuo L; Gray NA; de Zoysa JR; Chan CT; Lin H; Zhang L; Xu J; Cass A; Gallagher M; Perkovic V; Jardine M, 2019, 'Varying association of extended hours dialysis with quality of life', Clinical Journal of the American Society of Nephrology, 14, pp. 1751 - 1762, http://dx.doi.org/10.2215/CJN.06800619

Goldstein CE; Weijer C; Taljaard M; Al-Jaishi AA; Basile E; Brehaut J; Cook CL; Grimshaw JM; Lacson E; Lindsay C; Jardine M; Dember LM; Garg AX, 2019, 'Ethical Issues in Pragmatic Cluster-Randomized Trials in Dialysis Facilities', American Journal of Kidney Diseases, 74, pp. 659 - 666, http://dx.doi.org/10.1053/j.ajkd.2019.04.019

Smyth B; Trongtrakul K; Haber A; Talbot B; Hawley C; Perkovic V; Woodward M; Jardine M, 2019, 'Inequities in the global representation of sites participating in large, multicentre dialysis trials: A systematic review', BMJ Global Health, 4, pp. e001940, http://dx.doi.org/10.1136/bmjgh-2019-001940

Neuen BL; Young T; Heerspink HJL; Neal B; Perkovic V; Billot L; Mahaffey KW; Charytan DM; Wheeler DC; Arnott C; Bompoint S; Levin A; Jardine MJ, 2019, 'SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis', The Lancet Diabetes and Endocrinology, 7, pp. 845 - 854, http://dx.doi.org/10.1016/S2213-8587(19)30256-6

Neuen BL; Cherney DZ; Jardine MJ; Perkovic V, 2019, 'Sodium-glucose cotransporter inhibitors in type 2 diabetes: Thinking beyond glucose lowering', CMAJ, 191, pp. E1128 - E1135, http://dx.doi.org/10.1503/cmaj.190047

Sarnak MJ; Amann K; Bangalore S; Cavalcante JL; Charytan DM; Craig JC; Gill JS; Hlatky MA; Jardine AG; Landmesser U; Newby LK; Herzog CA; Cheung M; Wheeler DC; Winkelmayer WC; Marwick TH; Banerjee D; Briguori C; Chang TI; Chen CL; deFilippi CR; Ding X; Ferro CJ; Gill J; Gössl M; Isbel NM; Ishii H; Jardine MJ; Kalra PA; Laufer G; Lentine KL; Lobdell K; Lok CE; London GM; Małyszko J; Mark PB; Marwan M; Nie Y; Parfrey PS; Pecoits-Filho R; Pilmore H; Qunibi WY; Raggi P; Rattazzi M; Rossignol P; Ruturi J; Sabanayagam C; Shanahan CM; Shroff GR; Shroff R; Webster AC; Weiner DE; Winther S; Wiseman AC; Yip A; Zarbock A, 2019, 'Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review', Journal of the American College of Cardiology, 74, pp. 1823 - 1838, http://dx.doi.org/10.1016/j.jacc.2019.08.1017

Zhou Z; Jardine M; Perkovic V; Matthews DR; Mahaffey KW; de Zeeuw D; Fulcher G; Desai M; Oh R; Simpson R; Watts NB; Neal B, 2019, 'Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program', Diabetologia, 62, pp. 1854 - 1867, http://dx.doi.org/10.1007/s00125-019-4955-5

Gray NA; Zuo L; Hong D; Smyth B; Jun M; De Zoysa J; Vo K; Howard K; Wang J; Lu C; Liu Z; Cass A; Perkovic V; Jardine M, 2019, 'Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial', Nephrology, 24, pp. 1056 - 1063, http://dx.doi.org/10.1111/nep.13530

Smyth B; Haber A; Trongtrakul K; Hawley C; Perkovic V; Woodward M; Jardine M, 2019, 'Representativeness of Randomized Clinical Trial Cohorts in End-stage Kidney Disease: A Meta-analysis', JAMA Internal Medicine, 179, pp. 1316 - 1324, http://dx.doi.org/10.1001/jamainternmed.2019.1501

Jardine MJ; Mahaffey KW; Perkovic V, 2019, 'Canagliflozin and Renal Outcomes in Diabetic Nephropathy. Reply', The New England journal of medicine, 381, pp. 1089 - 1090, http://dx.doi.org/10.1056/NEJMc1909687

Mahaffey KW; Jardine MJ; Bompoint S; Cannon CP; Neal B; Heerspink HJL; Charytan DM; Edwards R; Agarwal R; Bakris G; Bull S; Capuano G; De Zeeuw D; Greene T; Levin A; Pollock C; Sun T; Wheeler DC; Yavin Y; Zhang H; Zinman B; Rosenthal N; Brenner BM; Perkovic V, 2019, 'Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial', Circulation, 140, pp. 739 - 750, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.042007

Wyld MLR; Morton RL; Clayton P; Wong MG; Jardine M; Polkinghorne K; Chadban S, 2019, 'The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study', Quality of Life Research, 28, pp. 2081 - 2090, http://dx.doi.org/10.1007/s11136-019-02173-1

Ha JT; Neuen BL; Cheng LP; Jun M; Toyama T; Gallagher MP; Jardine MJ; Sood MM; Garg AX; Palmer SC; Mark PB; Wheeler DC; Jha V; Freedman B; Johnson DW; Perkovic V; Badve SV, 2019, 'Benefits and harms of oral anticoagulant therapy in chronic kidney disease', Annals of Internal Medicine, 171, pp. 181 - 189, http://dx.doi.org/10.7326/M19-0087

Zhan Z; Smyth B; Toussaint ND; Gray NA; Zuo L; De Zoysa JR; Chan CT; Jin C; Scaria A; Hawley CM; Perkovic V; Jardine MJ; Zhang L, 2019, 'Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study', BMC Nephrology, 20, pp. 258, http://dx.doi.org/10.1186/s12882-019-1438-3

Graham-Brown MPM; Jardine MJ; Burton JO, 2019, 'Cardiovascular adaptations associated with exercise in patients on hemodialysis', Seminars in Dialysis, 32, pp. 361 - 367, http://dx.doi.org/10.1111/sdi.12789

Jardine MJ; Li N; Ninomiya T; Feng X; Zhang J; Shi J; Zhang Y; Zhang R; Zhang J; Hao J; Perkovic V; Heerspink HL; Wu Y; Yan LL; Neal B, 2019, 'Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial', Journal of Renal Nutrition, 29, pp. 276 - 284, http://dx.doi.org/10.1053/j.jrn.2018.10.009

Perkovic V; Jardine MJ; Neal B; Bompoint S; Heerspink HJL; Charytan DM; Edwards R; Agarwal R; Bakris G; Bull S; Cannon CP; Capuano G; Chu PL; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler DC; Yavin Y; Zhang H; Zinman B; Meininger G; Brenner BM; Mahaffey KW; Jha V, 2019, 'Canagliflozin and renal outcomes in type 2 diabetes and nephropathy', New England Journal of Medicine, 380, pp. 2295 - 2306, http://dx.doi.org/10.1056/NEJMoa1811744

Wong MG; Ninomiya T; Liyanage T; Sukkar L; Hirakawa Y; Wang Y; Wyld MLR; Morton RL; Chadban S; Howard K; Jardine MJ, 2019, 'Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 quality of life: An AusDiab analysis', Nephrology, 24, pp. 605 - 614, http://dx.doi.org/10.1111/nep.13445

Toyama T; Neuen BL; Jun M; Ohkuma T; Neal B; Jardine MJ; Heerspink HL; Wong MG; Ninomiya T; Wada T; Perkovic V, 2019, 'Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis', Diabetes, Obesity and Metabolism, 21, pp. 1237 - 1250, http://dx.doi.org/10.1111/dom.13648

Liu Y; Hong D; Wang AY; Guo R; Smyth B; Liu J; Sun G; Chen S; Tan N; Jardine M; Brieger D; Shaman A; Islam S; Chen J; Gallagher M; Wang Y, 2019, 'Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials', BMC Cardiovascular Disorders, 19, pp. 87, http://dx.doi.org/10.1186/s12872-019-1054-y

Liao JL; van den Broek-Best O; Smyth B; Hong D; Vo K; Zuo L; Gray NA; Chan CT; de Zoysa J; Perkovic V; Jiang L; Jardine M, 2019, 'Effect of extended hours dialysis on sleep quality in a randomized trial', Nephrology, 24, pp. 430 - 437, http://dx.doi.org/10.1111/nep.13236

Jun M; Jardine MJ; Perkovic V; Pilard Q; Billot L; Rodgers A; Rogers K; Gallagher M, 2019, 'Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study', PLoS ONE, 14, pp. e0213192, http://dx.doi.org/10.1371/journal.pone.0213192

Lioufas N; Toussaint ND; Pedagogos E; Elder G; Badve SV; Pascoe E; Valks A; Hawley C; Block GA; Boudville NC; Campbell K; Cameron JD; Chen SSM; Faull RJ; Holt SG; Hooi LS; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Morrish A; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM; Badve S, 2019, 'Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study', BMJ Open, 9, pp. e024382, http://dx.doi.org/10.1136/bmjopen-2018-024382

Lee EJ; Patel A; Acedillo RR; Bachynski JC; Barrett I; Basile E; Battistella M; Benjamin D; Berry D; Blake PG; Chan P; Bohm CJ; Clemens KK; Cook C; Dember L; Dirk JS; Dixon S; Fowler E; Getchell L; Gholami N; Goldstein C; Hahn E; Hogeterp B; Huang S; Hughes M; Jardine MJ; Kalatharan S; Kilburn S; Lacson E; Leonard S; Liberty C; Lindsay C; MacRae JM; Manns BJ; McCallum J; McIntyre CW; Molnar AO; Mustafa RA; Nesrallah GE; Oliver MJ; Pandes M; Pandeya S; Parmar MS; Rabin EZ; Riley J; Silver SA; Sontrop JM; Sood MM; Suri RS; Tangri N; Tascona DJ; Thomas A; Wald R; Walsh M; Weijer C; Weir MA; Vorster H; Zimmerman D; Garg AX, 2019, 'Cultivating Innovative Pragmatic Cluster-Randomized Registry Trials Embedded in Hemodialysis Care: Workshop Proceedings From 2018', Canadian Journal of Kidney Health and Disease, 6, http://dx.doi.org/10.1177/2054358119894394

Neuen BL; Ohkuma T; Neal B; Matthews DR; De Zeeuw D; Mahaffey KW; Fulcher G; Li Q; Jardine M; Oh R; Heerspink HL; Perkovic V, 2019, 'Effect of canagliflozin on renal and cardiovascular outcomes across different levels of albuminuria: Data from the CANVAS program', Journal of the American Society of Nephrology, 30, pp. 2229 - 2242, http://dx.doi.org/10.1681/ASN.2019010064

Jardine M; Commons RJ; de Zoysa JR; Wong MG; Gilroy N; Green J; Henderson B; Stuart RL; Tunnicliffe DJ; van Eps C; Athan E, 2019, 'Kidney Health Australia - Caring for Australasians with Renal Impairment guideline recommendations for infection control for haemodialysis units', Nephrology, 24, pp. 951 - 957, http://dx.doi.org/10.1111/nep.13511

Sukkar L; Talbot B; Jun M; Dempsey E; Walker R; Hooi L; Cass A; Jardine M; Gallagher M, 2019, 'Protocol for the Study of Heart and Renal Protection-Extended Review: Additional 5-Year Follow-up of the Australian, New Zealand, and Malaysian SHARP Cohort', Canadian Journal of Kidney Health and Disease, 6, pp. 2054358119879896, http://dx.doi.org/10.1177/2054358119879896

Smyth B; Krishnan AV; Gallagher M; Kiernan M; Snelling P; Hawley C; Fernando M; Hand S; Grimley K; Burman J; Heath A; Kang A; Perkovic V; Jardine MJ, 2019, 'Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol', BMJ Open, 9, pp. bmjopen-2018-023736, http://dx.doi.org/10.1136/bmjopen-2018-023736

Neuen B; Heerspink H; Neal B; Matthews D; de Zeeuw D; Mahaffey K; Davidson J; Jardine M; Zoungas S; Perkovic V, 2019, 'Abstract #259 Cardiovascular and Renal Outcomes with Canagliflozin in People with Type 2 Diabetes According to Baseline use of Metformin', Endocrine Practice, 25, pp. 99 - 100, http://dx.doi.org/10.1016/s1530-891x(20)46603-0

Smyth B; Haber A; Trongtrakul K; Hawley C; Perkovic V; Woodward M; Jardine M, 2019, 'SAT-041 A META-ANALYSIS OF THE REPRESENTATIVENESS OF RANDOMIZED CONTROLLED TRIAL COHORTS IN END-STAGE KIDNEY DISEASE', Kidney International Reports, 4, pp. S21 - S21, http://dx.doi.org/10.1016/j.ekir.2019.05.064

HOCKHAM C; Kang A; Young T; Sukkar L; Jun M; Rogers K; Baker J; Cass A; Jardine M, 2019, 'SAT-241 SMALL AREA-LEVEL VARIATION IN CHRONIC KIDNEY DISEASE PREVALENCE AND INCIDENCE IN NEW SOUTH WALES', Kidney International Reports, 4, pp. S108 - S108, http://dx.doi.org/10.1016/j.ekir.2019.05.277

YOUNG T; Hockham C; Sukkar L; Kang A; Jun M; Baker J; Rogers K; Cass A; Jardine M, 2019, 'SAT-288 Trends in pharmacotherapy for diabetes in a large Australian cohort: results from the EXTEND45 study', Kidney International Reports, 4, pp. S128 - S129, http://dx.doi.org/10.1016/j.ekir.2019.05.326

Young T; Hockham C; Sukkar L; Kang A; Jun M; Baker J; Rogers K; Cass A; Jardine M, 2019, 'SAT-289 Association between the intensity of diabetes pharmacotherapy regimens, persistence and achieved HbA1c in a large Australian cohort: results from the EXTEND45 study', Kidney International Reports, 4, pp. S129 - S129, http://dx.doi.org/10.1016/j.ekir.2019.05.327

Toyama T; NEUEN B; Jun M; Ohkuma T; Neal B; Jardine M; Heerspink H; Ninomiya T; Wada T; Perkovic V, 2019, 'SAT-298 EFFECT OF SGLT2 INHIBITORS ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE', Kidney International Reports, 4, pp. s133, http://dx.doi.org/10.1016/j.ekir.2019.05.338

Tong A; Manns B; Wang AYM; Hemmelgarn B; Wheeler DC; Gill J; Tugwell P; Pecoits-Filho R; Crowe S; Harris T; Van Biesen W; Winkelmayer WC; Levin A; Thompson A; Perkovic V; Ju A; Gutman T; Bernier-Jean A; Viecelli AK; O'Lone E; Shen J; Josephson MA; Cho Y; Johnson DW; Sautenet B; Tonelli M; Craig JC; Sinha A; Ong A; Denny A; Dart A; Eddy A; Kelly A; Davenport A; Narva A; Sharma A; Warrens A; Chapman A; Teixeira-Pinto A; Murphy B; Padilla B; Canaud B; Pullin B; Schiller B; Robinson B; Hanson C; Hawley C; Logeman C; Lok C; Wanner C; Herzog C; Rutherford C; Ahn C; Sumpton D; Rosenbloom D; Harris D; Baron D; White D; Gipson D; Fouque D; Eilers D; Bockenhauer D; O'Donoghue D; Chen D; Dunning D; Brown E; Bavlovlenkov E; Mannon E; Poggio E; Chemla E; Dobbels F; Zannad F; Caskey F; Tentori F; Hurst F; Schaefer F; Wong G; Brunier G; Strippoli G; Rangan G; Knoll G; Obrador G; Feldman H; Coolican H; Yap HK; Groothoff J; Sloand J; Tan J; Locke J; Perl J; Chapman J; Dong J; Malyszko J; Fox J; Dapueto J; Tze-Wah Kao J; Chow KM; Manera K; Azukaitis K; Polkinghorne K, 2018, 'Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop', Kidney International, 94, pp. 1053 - 1068, http://dx.doi.org/10.1016/j.kint.2018.08.018

Wong MG; Jardine M; Perkovic V, 2018, 'Glucose lowering and the kidney: are all drug classes equal?', The Lancet Diabetes and Endocrinology, 6, pp. 835 - 837, http://dx.doi.org/10.1016/S2213-8587(18)30291-2

Neuen BL; Ohkuma T; Neal B; Matthews DR; Mahaffey KW; Fulcher G; Desai M; Li Q; Deng H; Rosenthal N; Jardine M; Bakris G; Perkovic V, 2018, 'Canagliflozin and Cardiovascular (CV) Outcomes in Patients with Chronic Kidney Disease', DIABETES, 67, http://dx.doi.org/10.2337/db18-258-OR

O'Lone E; Viecelli AK; Craig JC; Tong A; Sautenet B; Roy D; Herrington WG; Herzog CA; Jafar T; Jardine M; Krane V; Levin A; Malyszko J; Rocco MV; Strippoli G; Tonelli M; Wang AYM; Wanner C; Zannad F; Winkelmayer WC; Webster AC; Wheeler DC, 2018, 'Cardiovascular Outcomes Reported in Hemodialysis Trials', Journal of the American College of Cardiology, 71, pp. 2802 - 2810, http://dx.doi.org/10.1016/j.jacc.2018.04.012

Wolley M; Jardine M; Hutchison CA, 2018, 'Exploring the clinical relevance of providing increased removal of large middle molecules', Clinical Journal of the American Society of Nephrology, 13, pp. 805 - 814, http://dx.doi.org/10.2215/CJN.10110917

Smyth B; Kotwal S; Gallagher M; Jardine M, 2018, 'FP513CARDIOVASCULAR EVENTS IN A LINKED DATA COHORT OF DIALYSIS PATIENTS: IMPACT OF MODALITY AND EVENT DEFINITION', Nephrology Dialysis Transplantation, 33, pp. i211 - i211, http://dx.doi.org/10.1093/ndt/gfy104.fp513

de Zeeuw D; Heerspink HJL; Jardine M; Perkovic V, 2018, 'Renal trials in diabetes need a platform: time for a global approach?', The Lancet Diabetes and Endocrinology, 6, pp. 356 - 358, http://dx.doi.org/10.1016/S2213-8587(17)30263-2

Back to profile page